Other News

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

SHANGHAI, June 29, 2023 /PRNewswire/ — Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment […]

Ardelyx, Inc. Reports Employment Inducement Grants

WALTHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on June 28, 2023, the compensation committee of the company’s board of directors granted four new […]

Alnylam Announces Date of Planned FDA Advisory Committee Meeting for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has set a date of September 13, 2023 for the meeting of the Cardiovascular and Renal Drugs Advisory Committee to review the supplemental New Drug Application for patisiran, an […]

PocDoc partners with NHS Targeted Lung Health Programme in North East, leveraging new biomarker Coronary Artery Calcium, to identify patients at increased risk of cardiovascular disease

CAMBRIDGE, England, June 29, 2023 /PRNewswire/ — PocDoc, the Cambridge-based digital health platform, today announces a major pilot with the NHS Targeted Lung Health Check programme in the North East, in partnership with cardiologist Dr Alan Bagnall and the NIHR Clinical Research Network North East and North Cumbria (CRN NENC). As documented widely in recent weeks, the NHS England Targeted […]

Core Sound Imaging’s Studycast Integration Program impacts hospital workflows

[Health System in New York City pilots the Studycast Integration Program using Us2.ai’s complete echo AI tools for automating echo measurements. Core Sound Imaging’s Studycast Integration Program has been designed to deliver a frictionless workflow for AI tools.] RALEIGH, N.C., June 28, 2023 /PRNewswire/ — Core Sound Imaging, Inc., creators of the Studycast® system, and Us2.ai […]

Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands

The acquisition gives access to a patented, innovative, and proven next-generation Drug Coated Balloon (DCB) technology that may revolutionize the scope of complex coronary interventions NEW DELHI and HELMOND, Netherlands, June 29, 2023 /PRNewswire/ — Translumina, a global leader in Interventional Cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Blue […]

Rivus Pharmaceuticals Announces Leadership Transition, Appointment of Jayson Dallas, M.D., as CEO

–  Allen Cunningham appointed Chief Operating Officer, guiding execution of the company’s clinical programs for HU6 to treat cardiometabolic disease CHARLOTTESVILLE, Va. and SAN FRANCISCO, June 29, 2023 /PRNewswire/ — Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardiometabolic health, today announced the appointment of Jayson Dallas, M.D., executive chairman for Rivus Pharmaceuticals, as Chief Executive […]

Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US

HINGHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced the successful completion of an extended pre-clinical study held by leading key opinion leaders (“KOLs”) at a New York-based research lab. […]